europium has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beck-Nielsen, H; Handberg, A; Hoppe, E; Vinten, J; Worm, D | 1 |
| Baba, S; Okada, Y; Shii, K; Yoshida, M | 1 |
2 other study(ies) available for europium and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Decreased skeletal muscle phosphotyrosine phosphatase (PTPase) activity towards insulin receptors in insulin-resistant Zucker rats measured by delayed Europium fluorescence.
Topics: Adenosine Triphosphate; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Europium; Fluorescent Antibody Technique; Humans; Insulin; Insulin Resistance; Kinetics; Metformin; Muscle, Skeletal; Obesity; Protein Tyrosine Phosphatases; Rats; Rats, Zucker; Receptor, Insulin; Reference Values; Spectrometry, Fluorescence | 1996 |
Development of vanadate sensitive human erythrocytes insulin receptor tyrosine phosphatase assay.
Topics: Animals; Antibodies, Monoclonal; CHO Cells; Cricetinae; Diabetes Mellitus, Type 2; Erythrocytes; Europium; Fluorometry; Humans; Insulin; Middle Aged; Phosphorylation; Protein Tyrosine Phosphatases; Receptor, Insulin; Vanadates | 1998 |